Novo stops research on diabetes molecule
Danish pharma giant Novo Nordisk has decided to completely stop all research on one of Dr Reddy's diabetes molecule - DRF 2725 (Ragaglitazar). However, Novo Nordisk has decided to move forward on the
Danish pharma giant Novo Nordisk has decided to completely stop all research on one of Dr Reddy's diabetes molecule - DRF 2725 (Ragaglitazar). However, Novo Nordisk has decided to move forward on the